The pooled estimate suggested a trend towards reduced risk among GLP-1 RA users, though this did not reach statistical significance (OR 0.84, 95% CI 0.69-1.03, p = 0.09; I 2 = 7%) (Figure 3 ).
← all excerpts
Impact of Glucagon-Like Peptide-1 Receptor Agonists on Hip Arthroplasty Outcomes: A Systematic Review and Meta-Analysis.
1
0.0900
0.0900